所有類別 Hepatocellular carcinomaThe 1st TASL-AASLD Joint Symposium: HBV EliminatioTASL 2021 HCC Single Topic Conference-symposiumThe 2st TASL-AASLD Joint Symposium認識B肝與治療 The 1st TASL-AASLD Joint Symposium: HBV Eliminatio How to achieve WHO goal to eliminate HBV in 2030: Efforts from Taiwan 影片長度: Prof. Ding-Shinn Chen The 1st TASL-AASLD Joint Symposium: HBV Eliminatio WHO efforts towards elimination of HBV in the rest of the World 影片長度: Prof. K. Rajender Reddy The 1st TASL-AASLD Joint Symposium: HBV Eliminatio Definition of HBV cure and strategies to achieve HBV cure: Updates from 2019 EASL-AASLD HBV treatmen 影片長度: Prof. Anna Suk-Fong Lok The 1st TASL-AASLD Joint Symposium: HBV Eliminatio Finite nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm sh 影片長度: Prof. Yun-Fan Liaw The 1st TASL-AASLD Joint Symposium: HBV Eliminatio Indications for hepatitis B treatment – are current guidelines too strict? 影片長度: Prof. Anna Suk-Fong Lok 第一頁 < 1 2 > 到最後 ,前往第 1 2 頁